Cost and time for clinical development constitute more than 70% of total development of any drug! Small – mid scale biopharma are known for their innovative approaches, agility and faster developments. However, clinical development has always been one step too important, yet too hard for them. There are ways to overcome these challenges and optimize […]

Read More →

Increased outsourcing is seen in pharmaceutical and biotechnology companies, with 85 percent comprised of the clinical segment, the global CRO market was estimated at $31.6 billion in 2018 and is expected to grow at a CAGR of 12 percent to reach $45.2 billion by 2022 according to a report. What is a CRO? Contract research […]

Read More →

Over a few years, the rate of drug development in rare diseases is increasing, particularly in those countries where the regulators are offering various incentives for drug development in rare diseases. Over the past five years, one-third of the approved drugs were to treat rare diseases. The huge leap of pharma industry into the rare […]

Read More →